HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

5th Edition of

International Ophthalmology Conference

Complications in primary vs secondary enucleation in patients with retinoblastoma: Analysis from a children eye cancer centre in Pakistan

Rabeeah Zafar
Al-Shifa Trust Eye Hospital, Pakistan
Title: Complications in primary vs secondary enucleation in patients with retinoblastoma: Analysis from a children eye cancer centre in Pakistan

Abstract:

Objective: To evaluate the complications after primary and secondary enucleation in children with retinoblastoma

Method: This prospective cohort study was conducted from January 1, 2017, to December 31, 2022, at the Children Eye Hospital, Al-Shifa Trust, Rawalpindi, Pakistan, and comprised children with retinoblastoma who underwent enucleation. Post-enucleated sockets in the patients were evaluated for any post-operative complications. Data was analysed using SPSS 26.

Results: Of the 133 patients with mean age 28.1±19.1 months, 77(58%) were boys and 56(42%) were girls. Overall, 74(56%) patients had primary enucleation, 59(44%) had secondary enucleation, 79(59%) had unilateral disease and 54(41%) had bilateral retinoblastoma. Family history was positive in 23(17%) patients. The difference between age at presentation between primary and secondary enucleation was not significant (p=0.619). Complications were observed in 28(21.1%) sockets, the most common being implant exposure 9(32%). The rate of complications between primary and secondary enucleation cases was not significant (p=0.80). Female gender (p=0.02, odds ratio: 1.6, 95% confidence interval: 1.109-2.410), intravenous chemotherapy (p=0.11, odds ratio: 1.2 95%, confidence interval: 0.980-1.594), high-risk features (p=0.02, odds ratio: 1.7 95%, confidence interval: 1.127-2.608) and extraocular disease (p=0.49, odds ratio: 1.1, 95% confidence interval: 0.759-1.796) were associated with greater odds of developing complications post-enucleation.

Conclusion: Complications were observed in more than one-fourth of the enucleated sockets. Intravenous chemotherapy, female gender, high-risk features and extraocular retinoblastoma added to the burden of post-operative complications.

Biography:

Dr. Rabeeah Zafar embarked on her ophthalmology career in 2014 as a resident trainee, later earning her FCPS- General Ophthalmology in 2019 and FCPS- Pediatric Ophthalmology and Strabismus in 2025 from the College of Physicians & Surgeons Pakistan. She is also Fellow of International Council of Ophthalmology (FICO) from UK. Currently, she is serving as an Assistant Professor in Children Eye Hospital, Al-Shifa Trust Rawalpindi, contributing significantly to pediatric eye care in Pakistan. Dr. Zafar's dedication extends to research, with notable publications and presentations in national and international forums. She also plays a vital role as a reviewer for leading ophthalmology journals. Committed to professional development, she holds memberships in prestigious medical bodies and actively engages in philanthropic initiatives, including her role as a founding and executive member of The Saving Smiles Foundation. Dr. Zafar's multifaceted contributions underscore her commitment to advancing ophthalmology and improving eye healthcare for children in Pakistan and beyond.

YouTube
WhatsAppWhatsApp